HUDA Hudson Acquisition I Corp
- 12.050
- -2.150-15.14%
Hudson Acquisition I Corp News
On March 12, 2024, Hudson Acquisition I Appointed Warren Wang As Its Chief Executive Officer And Chairman Of Board; Jiang Hui Resigned As Chief Executive Officer And Chairman Of Board
On March 12, 2024, Hudson Acquisition I Appointed Warren Wang As Its Chief Executive Officer And Chairman Of Board; Jiang Hui Resigned As Chief Executive Officer And Chairman Of Board
Hudson Acquisition I Corp. Announced That It Received A Notice From The Listing Qualifications Department Of The Nasdaq Stock Market Stating That The Company Has Regained Compliance With The Nasdaq Listing Rule 5250(C)(1)
Hudson Acquisition I Corp. Announced That It Received A Notice From The Listing Qualifications Department Of The Nasdaq Stock Market Stating That The Company Has Regained Compliance With The Nasdaq Li
Hudson Acquisition I Gets Nasdaq Notification Regarding Minimum Market Value Deficiency
Hudson Acquisition I Receives Non-Compliance Notification From Nasdaq
Hudson Acquisition I (HUDA) said late Thursday it was notified by Nasdaq that the company is not in compliance with the exchange's requirement for continued listing relating to the minimum market valu
Hudson Acquisition I Corp. Receives Notification From Nasdaq Regarding Minimum Market Value Deficiency
Hudson Acquisition I Corp. (Nasdaq: HUDA), announced today that it received a notice (the "Notice") from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") on December 15, 2023, indicating that the Company is currently not in compliance with the minimum Market Value of Listed Securities ("MVLS") set forth in the Nasdaq Rules for continued listing on the Nasdaq Global Market.
Hudson Acquisition I CFO Passes Away
Hudson Acquisition I (HUDA) on Monday announced the passing of its chief financial officer Hon Man Yun. Yun had been serving as the company's CFO since 2022.
Hudson Acquisition I Corp. Mourns The Loss Of Chief Financial Officer, Mr. Hon Man Yun
Hudson Acquisition I Corp. (the "Company" or "Hudson") (NASDAQ:HUDA), announced today that Mr. Hon Man Yun, the Chief Financial Officer of the Company, passed away on October 3, 2023. The entire Hudso
Hudson Acquisition Receives Non-Compliance Notice From Nasdaq
Hudson Acquisition I Corp. (HUDA) said Friday it has been notified that it is not in compliance with the Nasdaq Stock Market's listing rules for failure to timely file its quarterly report on Form 10-
Hudson Acquisition I Corp Announces Receipt of Nasdaq Notice
Hudson Acquisition I Corp. Receives Notification Of Deficiency From Nasdaq Related To Delayed Filing Of Its Form 10-Q
 Hudson Acquisition I Corp. (the "Company" or "Hudson") (NASDAQ:HUDA), announced today that it received a notice (the "Notice") from the Listing Qualifications Department of the Nasdaq Stock Market
Hudson Acquisition Gets Nasdaq Non-Compliance Notice
04:44 AM EDT, 04/25/2023 (MT Newswires) -- Hudson Acquisition I Corp. (HUDA) said Monday it has been notified that it is not in compliance with Nasdaq's listing rules for failure to timely file its Fo
Hudson Acquisition I: Working Diligently to Complete Form 10-K, Anticipates Filing 10-K as Promptly as Practicable >HUDA
Hudson Acquisition I: Working Diligently to Complete Form 10-K, Anticipates Filing 10-K as Promptly as Practicable >HUDA
Hudson Acquisition I Corp.: Receives Notification of Deficiency From Nasdaq Related to Delayed Annual Report on Form 10-K
Hudson Acquisition I Corp.: Receives Notification of Deficiency From Nasdaq Related to Delayed Annual Report on Form 10-K
Hudson Acquisition I Corp.'s (NASDAQ:HUDAU) Lock-Up Period Will Expire Tomorrow
Hudson Acquisition I's (NASDAQ:HUDAU – Get Rating) lock-up period is set to expire on Wednesday, April 12th. Hudson Acquisition I had issued 6,000,000 shares in its initial public offering on October
Hudson Acquisition I: Target Co Is a Pre-Clinical-Stage Biotechnology Co Focused on Developing Intranasal Preventives for Major Disease-Causing Respiratory Viruses >HUDA
Hudson Acquisition I: Target Co Is a Pre-Clinical-Stage Biotechnology Co Focused on Developing Intranasal Preventives for Major Disease-Causing Respiratory Viruses >HUDA
Hudson Acquisition I Corp. Announces Letter of Intent for Business Combination
Hudson Acquisition I Corp. Announces Letter of Intent for Business Combination
Hudson Acquisition I Says Regains Compliance With Nasdaq Listing Rule 5250(c)(1)
Hudson Acquisition I Says Regains Compliance With Nasdaq Listing Rule 5250(c)(1)
Analysis
Price Target
No Data
